Evidence map›Paper›PMID 33654208›Full record

ArticleLeukemia2021

Enhanced thrombin/PAR1 activity promotes G-CSF- and AMD3100-induced mobilization of hematopoietic stem and progenitor cells via NO upregulation.

Neta Nevo, Lizeth-Alejandra Ordonez-Moreno, Shiri Gur-Cohen, Francesca Avemaria, Suditi Bhattacharya, Eman Khatib-Massalha, Mayla Bertagna, Montaser Haddad, Priyasmita Chakrabarti, Wolfram Ruf and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Neta Nevo *Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Lizeth-Alejandra Ordonez-Moreno *Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Shiri Gur-CohenDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Francesca AvemariaDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Suditi BhattacharyaDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Eman Khatib-MassalhaDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Mayla BertagnaDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Montaser HaddadDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Priyasmita ChakrabartiDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Wolfram RufDepartment of Immunology and Microbial Science, Scripps Research, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-6064-2166
Tsvee LapidotDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel. tsvee.lapidot@weizmann.ac.il.ORCID http://orcid.org/0000-0001-9844-6454
Orit KolletDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel. orit.kollet@weizmann.ac.il.ORCID http://orcid.org/0000-0002-4912-4579

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-HIV AgentsApoptosisBenzylaminesCell ProliferationCells, CulturedCyclamsGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell MobilizationHematopoietic Stem CellsMiceNitric OxideReceptor, PAR-1ThrombinAnti-HIV AgentsBenzylaminesCyclamsGranulocyte Colony-Stimulating FactorNitric OxideplerixaforReceptor, PAR-1Thrombin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.